# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Keybanc analyst Scott Schoenhaus maintains Certara (NASDAQ:CERT) with a Overweight and lowers the price target from $23 to $20.
JMP Securities analyst Constantine Davides reiterates Certara (NASDAQ:CERT) with a Market Perform.
Certara, excluding Chemaxon, is reiterating 2024 revenue, adjusted EBITDA margin, and adjusted diluted earnings per share guida...
The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing con...
Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the price target from $18 to $16.
Certara (NASDAQ:CERT) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. The company rep...